CA Stock MarketDetailed Quotes

METX ME Therapeutics Holding Inc

Watchlist
  • 9.000
  • 0.0000.00%
15min DelayTrading Apr 11 15:59 ET
235.71MMarket Cap-180.00P/E (TTM)

ME Therapeutics Holding Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
41.18%204.81K
-10.91%308.92K
35.72%1.33M
-16.65%324.77K
-1.28%509.86K
310.29%145.07K
475.22%346.76K
624.06%977.37K
389.67K
516.45K
Selling and administrative expenses
95.90%124.84K
-14.94%254.62K
11.68%1.06M
-28.15%279.8K
-14.95%418.31K
91.70%63.73K
396.55%299.34K
877.06%950.21K
--389.43K
--491.85K
-General and administrative expense
95.90%124.84K
-14.94%254.62K
11.68%1.06M
-28.15%279.8K
-14.95%418.31K
91.70%63.73K
396.55%299.34K
877.06%950.21K
--389.43K
--491.85K
Research and development costs
-26.85%59.49K
-34.50%43.77K
1,050.65%312.02K
19,880.89%44.96K
383.55%118.9K
3,769.12%81.33K
--66.83K
-50.40%27.12K
--225
--24.59K
Depreciation amortization depletion
186,063.64%20.48K
116,822.22%10.52K
-20.41%39
-25.00%9
-16.67%10
-15.38%11
--9
-19.67%49
--12
--12
-Depreciation and amortization
186,063.64%20.48K
116,822.22%10.52K
-20.41%39
-25.00%9
-16.67%10
-15.38%11
--9
-19.67%49
--12
--12
Other operating expenses
----
----
---46.78K
--0
---27.36K
----
---19.42K
----
----
----
Operating profit
-41.18%-204.81K
10.91%-308.92K
-35.72%-1.33M
16.65%-324.77K
1.28%-509.86K
-310.29%-145.07K
-475.22%-346.76K
-624.06%-977.37K
-389.67K
-516.45K
Net non-operating interest income (expenses)
206.80%4.83K
107.24%7.56K
705.70%31.82K
138.55%12.73K
136.21%13.87K
158.19%1.57K
29.11%3.65K
136.56%3.95K
5.34K
5.87K
Non-operating interest income
447.78%8.62K
183.63%10.34K
178.83%31.82K
138.55%12.73K
136.21%13.87K
671.57%1.57K
29.11%3.65K
--11.41K
--5.34K
--5.87K
Non-operating interest expense
--3.79K
--2.79K
--0
--0
--0
--0
--0
-30.91%7.46K
--0
--0
Other net income (expenses)
-5.55M
-2.56M
-2.98M
Special income (charges)
----
----
--0
--0
--0
----
----
---5.57M
----
----
-Less:Restructuring and mergern&acquisition
----
----
--0
--0
--0
----
----
--5.57M
----
----
Other non-operating income (expenses)
----
----
----
----
----
----
----
--20K
--3M
---2.98M
Income before tax
-39.37%-199.98K
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
Income tax
Earnings from equity interest net of tax
Net income
-39.37%-199.98K
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
Net income continuous operations
-39.37%-199.98K
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
---2.95M
---3.49M
Noncontrolling interests
Net income attributable to the company
-39.37%-199.98K
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-39.37%-199.98K
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
-276.99%-143.49K
-497.14%-343.11K
-4,372.64%-6.52M
-2.95M
-3.49M
Diluted earnings per share
0.00%-0.01
0.00%-0.01
81.93%-0.05
92.00%-0.01
86.74%-0.02
-509.01%-0.01
-303.39%-0.01
-4,299.75%-0.2767
-0.1251
-0.1508
Basic earnings per share
0.00%-0.01
0.00%-0.01
81.93%-0.05
92.00%-0.01
86.74%-0.02
-509.01%-0.01
-303.39%-0.01
-4,299.75%-0.2767
-0.1251
-0.1508
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 41.18%204.81K-10.91%308.92K35.72%1.33M-16.65%324.77K-1.28%509.86K310.29%145.07K475.22%346.76K624.06%977.37K389.67K516.45K
Selling and administrative expenses 95.90%124.84K-14.94%254.62K11.68%1.06M-28.15%279.8K-14.95%418.31K91.70%63.73K396.55%299.34K877.06%950.21K--389.43K--491.85K
-General and administrative expense 95.90%124.84K-14.94%254.62K11.68%1.06M-28.15%279.8K-14.95%418.31K91.70%63.73K396.55%299.34K877.06%950.21K--389.43K--491.85K
Research and development costs -26.85%59.49K-34.50%43.77K1,050.65%312.02K19,880.89%44.96K383.55%118.9K3,769.12%81.33K--66.83K-50.40%27.12K--225--24.59K
Depreciation amortization depletion 186,063.64%20.48K116,822.22%10.52K-20.41%39-25.00%9-16.67%10-15.38%11--9-19.67%49--12--12
-Depreciation and amortization 186,063.64%20.48K116,822.22%10.52K-20.41%39-25.00%9-16.67%10-15.38%11--9-19.67%49--12--12
Other operating expenses -----------46.78K--0---27.36K-------19.42K------------
Operating profit -41.18%-204.81K10.91%-308.92K-35.72%-1.33M16.65%-324.77K1.28%-509.86K-310.29%-145.07K-475.22%-346.76K-624.06%-977.37K-389.67K-516.45K
Net non-operating interest income (expenses) 206.80%4.83K107.24%7.56K705.70%31.82K138.55%12.73K136.21%13.87K158.19%1.57K29.11%3.65K136.56%3.95K5.34K5.87K
Non-operating interest income 447.78%8.62K183.63%10.34K178.83%31.82K138.55%12.73K136.21%13.87K671.57%1.57K29.11%3.65K--11.41K--5.34K--5.87K
Non-operating interest expense --3.79K--2.79K--0--0--0--0--0-30.91%7.46K--0--0
Other net income (expenses) -5.55M-2.56M-2.98M
Special income (charges) ----------0--0--0-----------5.57M--------
-Less:Restructuring and mergern&acquisition ----------0--0--0----------5.57M--------
Other non-operating income (expenses) ------------------------------20K--3M---2.98M
Income before tax -39.37%-199.98K12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M-2.95M-3.49M
Income tax
Earnings from equity interest net of tax
Net income -39.37%-199.98K12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M-2.95M-3.49M
Net income continuous operations -39.37%-199.98K12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M---2.95M---3.49M
Noncontrolling interests
Net income attributable to the company -39.37%-199.98K12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M-2.95M-3.49M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -39.37%-199.98K12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K-276.99%-143.49K-497.14%-343.11K-4,372.64%-6.52M-2.95M-3.49M
Diluted earnings per share 0.00%-0.010.00%-0.0181.93%-0.0592.00%-0.0186.74%-0.02-509.01%-0.01-303.39%-0.01-4,299.75%-0.2767-0.1251-0.1508
Basic earnings per share 0.00%-0.010.00%-0.0181.93%-0.0592.00%-0.0186.74%-0.02-509.01%-0.01-303.39%-0.01-4,299.75%-0.2767-0.1251-0.1508
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More